These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29476595)

  • 1. Neuroimaging genomic studies in major depressive disorder: A systematic review.
    Zhang HF; Mellor D; Peng DH
    CNS Neurosci Ther; 2018 Nov; 24(11):1020-1036. PubMed ID: 29476595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimaging Genomics a Predictor of Major Depressive Disorder (MDD).
    Jindal M; Chhetri A; Ludhiadch A; Singh P; Peer S; Singh J; Brar RS; Munshi A
    Mol Neurobiol; 2024 Jun; 61(6):3427-3440. PubMed ID: 37989980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convergent molecular, cellular, and cortical neuroimaging signatures of major depressive disorder.
    Anderson KM; Collins MA; Kong R; Fang K; Li J; He T; Chekroud AM; Yeo BTT; Holmes AJ
    Proc Natl Acad Sci U S A; 2020 Oct; 117(40):25138-25149. PubMed ID: 32958675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroimaging insights into the link between depression and Insomnia: A systematic review.
    Bagherzadeh-Azbari S; Khazaie H; Zarei M; Spiegelhalder K; Walter M; Leerssen J; Van Someren EJW; Sepehry AA; Tahmasian M
    J Affect Disord; 2019 Nov; 258():133-143. PubMed ID: 31401541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of genes and environment on brain alterations in Major Depressive Disorder: A review of twin studies: Special Section on "Translational and Neuroscience Studies in Affective Disorders". Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.
    Pigoni A; Delvecchio G; Altamura AC; Soares JC; Fagnani C; Brambilla P
    J Affect Disord; 2018 Jul; 234():346-350. PubMed ID: 29100658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular, Functional, and Structural Imaging of Major Depressive Disorder.
    Zhang K; Zhu Y; Zhu Y; Wu S; Liu H; Zhang W; Xu C; Zhang H; Hayashi T; Tian M
    Neurosci Bull; 2016 Jun; 32(3):273-85. PubMed ID: 27142698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of whole-exome sequencing and structural neuroimaging analysis in major depressive disorder: a joint study.
    Oh EY; Han KM; Kim A; Kang Y; Tae WS; Han MR; Ham BJ
    Transl Psychiatry; 2024 Mar; 14(1):141. PubMed ID: 38461185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimaging Biomarkers for Predicting Treatment Response and Recurrence of Major Depressive Disorder.
    Kang SG; Cho SE
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32245086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trajectories of major depression disorders: A systematic review of longitudinal neuroimaging findings.
    Dohm K; Redlich R; Zwitserlood P; Dannlowski U
    Aust N Z J Psychiatry; 2017 May; 51(5):441-454. PubMed ID: 27539592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetics of depression: a review.
    Levinson DF
    Biol Psychiatry; 2006 Jul; 60(2):84-92. PubMed ID: 16300747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Combined Study of SLC6A15 Gene Polymorphism and the Resting-State Functional Magnetic Resonance Imaging in First-Episode Drug-Naive Major Depressive Disorder.
    Wang L; Liu Z; Cao X; Li J; Zhang A; Sun N; Yang C; Zhang K
    Genet Test Mol Biomarkers; 2017 Sep; 21(9):523-530. PubMed ID: 28915082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rise and fall of MRI studies in major depressive disorder.
    Zhuo C; Li G; Lin X; Jiang D; Xu Y; Tian H; Wang W; Song X
    Transl Psychiatry; 2019 Dec; 9(1):335. PubMed ID: 31819044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional alterations of the suicidal brain: An updated review of neuroimaging studies.
    Bani-Fatemi A; Tasmim S; Graff-Guerrero A; Gerretsen P; Strauss J; Kolla N; Spalletta G; De Luca V
    Psychiatry Res Neuroimaging; 2018 Aug; 278():77-91. PubMed ID: 29929763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational application of neuroimaging in major depressive disorder: a review of psychoradiological studies.
    Chen Z; Huang X; Gong Q; Biswal BB
    Front Med; 2021 Aug; 15(4):528-540. PubMed ID: 33511554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature.
    Lener MS; Iosifescu DV
    Ann N Y Acad Sci; 2015 May; 1344():50-65. PubMed ID: 25854817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does refining the phenotype improve replication rates? A review and replication of candidate gene studies on Major Depressive Disorder and Chronic Major Depressive Disorder.
    Luo X; Stavrakakis N; Penninx BW; Bosker FJ; Nolen WA; Boomsma DI; de Geus EJ; Smit JH; Snieder H; Nolte IM; Hartman CA
    Am J Med Genet B Neuropsychiatr Genet; 2016 Mar; 171B(2):215-36. PubMed ID: 26566975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No evidence of DISC1-associated morphological changes in the hippocampus, anterior cingulate cortex, or striatum in major depressive disorder cases and healthy controls.
    Stacey D; Redlich R; Opel N; Grotegerd D; Arolt V; Kugel H; Heindel W; Baune BT; Dannlowski U
    J Affect Disord; 2014 Sep; 166():103-7. PubMed ID: 25012417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal imaging reveals a complex pattern of dysfunction in corticolimbic pathways in major depressive disorder.
    Nugent AC; Farmer C; Evans JW; Snider SL; Banerjee D; Zarate CA
    Hum Brain Mapp; 2019 Sep; 40(13):3940-3950. PubMed ID: 31179620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroimaging Advance in Depressive Disorder.
    Peng D; Yao Z
    Adv Exp Med Biol; 2019; 1180():59-83. PubMed ID: 31784957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vulnerability for new episodes in recurrent major depressive disorder: protocol for the longitudinal DELTA-neuroimaging cohort study.
    Mocking RJ; Figueroa CA; Rive MM; Geugies H; Servaas MN; Assies J; Koeter MW; Vaz FM; Wichers M; van Straalen JP; de Raedt R; Bockting CL; Harmer CJ; Schene AH; Ruhé HG
    BMJ Open; 2016 Mar; 6(3):e009510. PubMed ID: 26932139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.